These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 15842551

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Diffusion of oral and intravenous 400 mg once-daily moxifloxacin into lung tissue at pharmacokinetic steady-state.
    Breilh D, Jougon J, Djabarouti S, Gordien JB, Xuereb F, Velly JF, Arvis P, Landreau V, Saux MC.
    J Chemother; 2003 Dec; 15(6):558-62. PubMed ID: 14998080
    [Abstract] [Full Text] [Related]

  • 45. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions.
    Marcelín-Jiménez G, Angeles-Moreno AP, Contreras-Zavala L, Morales-Martínez M, Rivera-Espinosa L.
    Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Penetration of moxifloxacin into bone in patients undergoing total knee arthroplasty.
    Malincarne L, Ghebregzabher M, Moretti MV, Egidi AM, Canovari B, Tavolieri G, Francisci D, Cerulli G, Baldelli F.
    J Antimicrob Chemother; 2006 May; 57(5):950-4. PubMed ID: 16551691
    [Abstract] [Full Text] [Related]

  • 48. Effect of oral charcoal and urine pH on dextropropoxyphene pharmacokinetics.
    Kärkkäinen S, Neuvonen PJ.
    Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23(4):219-25. PubMed ID: 2987139
    [Abstract] [Full Text] [Related]

  • 49. Relative oral bioavailability of morphine and naltrexone derived from crushed morphine sulfate and naltrexone hydrochloride extended-release capsules versus intact product and versus naltrexone solution: a single-dose, randomized-sequence, open-label, three-way crossover trial in healthy volunteers.
    Johnson FK, Stark JG, Bieberdorf FA, Stauffer J.
    Clin Ther; 2010 Jun; 32(6):1149-64. PubMed ID: 20637968
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Pharmacokinetics, safety and tolerability of moxifloxacin, a novel 8-methoxyfluoroquinolone, after repeated oral administration.
    Stass H, Kubitza D, Schühly U.
    Clin Pharmacokinet; 2001 Jun; 40 Suppl 1():1-9. PubMed ID: 11352436
    [Abstract] [Full Text] [Related]

  • 52. Effect of oral charcoal and urine pH on sotalol pharmacokinetics.
    Kärkkäinen S, Neuvonen PJ.
    Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):441-6. PubMed ID: 6092287
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Comparative bioavailability and pharmacokinetics of investigational enteric- and film-coated formulations of flurbiprofen 100-mg tablets: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Pakistani male volunteers.
    Ahmad M, Pervaiz F.
    Clin Ther; 2010 Mar; 32(3):607-13. PubMed ID: 20399997
    [Abstract] [Full Text] [Related]

  • 55. Effect of calcium supplements on the oral bioavailability of moxifloxacin in healthy male volunteers.
    Stass H, Wandel C, Delesen H, Möller JG.
    Clin Pharmacokinet; 2001 Mar; 40 Suppl 1():27-32. PubMed ID: 11352439
    [Abstract] [Full Text] [Related]

  • 56. Serum and prostatic tissue concentrations of moxifloxacin in patients undergoing transurethral resection of the prostate.
    Wagenlehner FM, Lunz JC, Kees F, Wieland W, Naber KG.
    J Chemother; 2006 Oct; 18(5):485-9. PubMed ID: 17127224
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Effects of charcoal on the absorption and elimination of the antiepileptic drugs lamotrigine and oxcarbazepine.
    Keränen T, Sorri A, Moilanen E, Ylitalo P.
    Arzneimittelforschung; 2010 Oct; 60(7):421-6. PubMed ID: 20712131
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.